Cargando…

The emerging role of PTBP1 in human cancer: novel prognostic factor in non-muscle invasive bladder cancer

Detalles Bibliográficos
Autores principales:	Bielli, Pamela, Di Stasi, Savino M., Sette, Claudio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2018
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323271/ https://www.ncbi.nlm.nih.gov/pubmed/30688932 http://dx.doi.org/10.21037/tau.2018.12.01

Ejemplares similares

Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells
por: Calabretta, Sara, et al.
Publicado: (2015)

Regulation of BCL-X splicing reveals a role for the polypyrimidine tract binding protein (PTBP1/hnRNP I) in alternative 5′ splice site selection
por: Bielli, Pamela, et al.
Publicado: (2014)

Comment on “The prognostic impact of tumor necrosis in non-muscle invasive bladder cancer”
por: Wang, Dexin, et al.
Publicado: (2023)

Comment on “Bladder Cancer–Specific Nuclear Matrix Proteins-4 May Be a Potential Biomarker for Non-Muscle-Invasive Bladder Cancer Detection”
por: Güllü Amuran, Gökçe
Publicado: (2019)

“Primary” and “secondary” muscle-invasive bladder cancer is more than just a surrogate for molecular subtypes
por: Pietzak, Eugene J., et al.
Publicado: (2019)

PTBP1 and PTBP2 impaired autoregulation of SRSF3 in cancer cells
por: Guo, Jihua, et al.
Publicado: (2015)

PTBP1 is a Novel Poor Prognostic Factor for Glioma
por: Liu, Pan, et al.
Publicado: (2022)

Identification of a gene signature for the prediction of recurrence and progression in non-muscle-invasive bladder cancer
por: Dalla, Emiliano, et al.
Publicado: (2022)

c-MYC empowers transcription and productive splicing of the oncogenic splicing factor Sam68 in cancer
por: Caggiano, Cinzia, et al.
Publicado: (2019)

Bladder Sparing Approaches for Muscle-Invasive Bladder Cancers
por: El-Taji, Omar M. S., et al.
Publicado: (2016)

Oncogenic dysregulation of pre‐mRNA processing by protein kinases: challenges and therapeutic opportunities
por: Naro, Chiara, et al.
Publicado: (2021)

Multi‐omics consensus ensemble refines the classification of muscle‐invasive bladder cancer with stratified prognosis, tumour microenvironment and distinct sensitivity to frontline therapies
por: Lu, Xiaofan, et al.
Publicado: (2021)

Lacking Evidence to Recommend Neoadjuvant Chemotherapy and Definitive Radiotherapy in Muscle-Invasive Bladder Cancer: In response to: Trimodality Therapy for Muscle-Invasive Bladder Cancer: Recent Advances and Unanswered Questions published by Di Maria Jiang et al. Current Oncology Reports 2020, https://doi.org/10.1007/s11912-020-0880-5
por: Böhmer, Dirk, et al.
Publicado: (2021)

Trimodality Treatment for Muscle-Invasive Bladder Cancer: An Institutional Experience
por: Polineni, Praneet, et al.
Publicado: (2021)

Letter to the Editor on the systematic review “Narrow band imaging versus white light cystoscopy alone for transurethral resection of non-muscle invasive bladder cancer”
por: Roupret, Morgan, et al.
Publicado: (2023)

Novel Therapies for High-Risk Non-Muscle Invasive Bladder Cancer
por: Al Hussein Al Awamlh, Bashir, et al.
Publicado: (2022)

High expression of PTBP1 promote invasion of colorectal cancer by alternative splicing of cortactin
por: Wang, Zhi-na, et al.
Publicado: (2017)

Histological variants in non-muscle invasive bladder cancer
por: Baumeister, Philipp, et al.
Publicado: (2019)

Emerging perioperative therapeutic approaches in muscle invasive bladder cancer
por: Patil, Goutham, et al.
Publicado: (2022)

A case of synchronous double malignancy: Invasive bladder cancer and Leiomyosarcoma of extremity and review of literature
por: Viveka, B. K., et al.
Publicado: (2013)

Expression signatures of exosomal long non-coding RNAs in urine serve as novel non-invasive biomarkers for diagnosis and recurrence prediction of bladder cancer
por: Zhan, Yao, et al.
Publicado: (2018)

A Novel DNA Methylation Signature as an Independent Prognostic Factor in Muscle-Invasive Bladder Cancer
por: Xu, Zhijie, et al.
Publicado: (2021)

The interplay between DNA damage response and RNA processing: the unexpected role of splicing factors as gatekeepers of genome stability
por: Naro, Chiara, et al.
Publicado: (2015)

Prognostic value of prostate volume in non-muscle invasive bladder cancer
por: Ham, Won Sik, et al.
Publicado: (2021)

Exploration of Prognostic Biomarkers of Muscle-Invasive Bladder Cancer (MIBC) by Bioinformatics
por: Xu, Xianglai, et al.
Publicado: (2021)

Prognostic value of hepatocyte growth factor for muscle-invasive bladder cancer
por: Katayama, Satoshi, et al.
Publicado: (2022)

The prognostic impact of tumor necrosis in non-muscle invasive bladder cancer
por: Culpan, Meftun, et al.
Publicado: (2022)

T1 Bladder Cancer: Comparison of the Prognostic Impact of Two Substaging Systems on Disease Recurrence and Progression and Suggestion of a Novel Nomogram
por: Asimakopoulos, Anastasios D., et al.
Publicado: (2021)

Bladder Preservation for Muscle Invasive Bladder Cancer
por: Mirza, Arafat, et al.
Publicado: (2016)

Epigenetically regulated gene expression profiles recognized three molecular classifications with prognostic and therapeutic implications in bladder cancer
por: Xu, Hui, et al.
Publicado: (2023)

The Emerging Role of the RBM20 and PTBP1 Ribonucleoproteins in Heart Development and Cardiovascular Diseases
por: Fochi, Stefania, et al.
Publicado: (2020)

A novel signature constructed by differential genes of muscle-invasive and non-muscle-invasive bladder cancer for the prediction of prognosis in bladder cancer
por: Wang, Weizhuo, et al.
Publicado: (2023)

Pioglitazone, bladder cancer, and detection bias
por: Dolin, Paul
Publicado: (2014)

Collagen stiffness promoted non-muscle-invasive bladder cancer progression to muscle-invasive bladder cancer
por: Zhu, Huier, et al.
Publicado: (2019)

FAM70B as a Novel Prognostic Marker for Cancer Progression and Cancer-Specific Death in Muscle-Invasive Bladder Cancer
por: Kang, Ho-Won, et al.
Publicado: (2012)

Clinicopathological significance and prognostic value of polypyrimidine tract binding protein 1 (PTBP1) in gastric cancer
por: Liu, Mengnan, et al.
Publicado: (2022)

The prognostic value of routine preoperative blood parameters in muscle-invasive bladder cancer
por: Zhang, Jingqi, et al.
Publicado: (2020)

Triple‐marker immunohistochemical assessment of muscle‐invasive bladder cancer: Is there prognostic significance?
por: Labban, Muhieddine, et al.
Publicado: (2021)

Prognostic value of albumin to globulin ratio in non-muscle-invasive bladder cancer
por: Quhal, Fahad, et al.
Publicado: (2021)

Alternative splicing patterns reveal prognostic indicator in muscle-invasive bladder cancer
por: AZhaTi, BaiHeTiYa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jh3rsfhcopcng20vucren9urck